nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Conjunctivitis—Auranofin—psoriatic arthritis	0.0384	0.0384	CcSEcCtD
Metipranolol—Visual impairment—Auranofin—psoriatic arthritis	0.0342	0.0342	CcSEcCtD
Metipranolol—Blepharitis—Dexamethasone—psoriatic arthritis	0.0305	0.0305	CcSEcCtD
Metipranolol—Blepharitis—Betamethasone—psoriatic arthritis	0.0305	0.0305	CcSEcCtD
Metipranolol—Rash—Auranofin—psoriatic arthritis	0.0159	0.0159	CcSEcCtD
Metipranolol—Dermatitis—Auranofin—psoriatic arthritis	0.0159	0.0159	CcSEcCtD
Metipranolol—Nausea—Auranofin—psoriatic arthritis	0.015	0.015	CcSEcCtD
Metipranolol—Bronchitis—Triamcinolone—psoriatic arthritis	0.0125	0.0125	CcSEcCtD
Metipranolol—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.0124	0.0124	CcSEcCtD
Metipranolol—Myocardial infarction—Prednisolone—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Metipranolol—Conjunctivitis—Prednisolone—psoriatic arthritis	0.0122	0.0122	CcSEcCtD
Metipranolol—Bradycardia—Prednisolone—psoriatic arthritis	0.0115	0.0115	CcSEcCtD
Metipranolol—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Metipranolol—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Metipranolol—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Metipranolol—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Metipranolol—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Metipranolol—Epistaxis—Triamcinolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Metipranolol—Visual impairment—Prednisolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Metipranolol—Bradycardia—Triamcinolone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Metipranolol—Bradycardia—Methylprednisolone—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Metipranolol—Rhinitis—Triamcinolone—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Metipranolol—Rhinitis—Methylprednisolone—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Metipranolol—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Metipranolol—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Metipranolol—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Metipranolol—Myocardial infarction—Betamethasone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Metipranolol—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Metipranolol—Conjunctivitis—Betamethasone—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Metipranolol—Visual impairment—Methylprednisolone—psoriatic arthritis	0.01	0.01	CcSEcCtD
Metipranolol—Bradycardia—Betamethasone—psoriatic arthritis	0.00961	0.00961	CcSEcCtD
Metipranolol—Bradycardia—Dexamethasone—psoriatic arthritis	0.00961	0.00961	CcSEcCtD
Metipranolol—Vision blurred—Prednisolone—psoriatic arthritis	0.00928	0.00928	CcSEcCtD
Metipranolol—Visual impairment—Betamethasone—psoriatic arthritis	0.00909	0.00909	CcSEcCtD
Metipranolol—Visual impairment—Dexamethasone—psoriatic arthritis	0.00909	0.00909	CcSEcCtD
Metipranolol—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00902	0.00902	CcSEcCtD
Metipranolol—Myocardial infarction—Prednisone—psoriatic arthritis	0.00897	0.00897	CcSEcCtD
Metipranolol—Hypertension—Prednisolone—psoriatic arthritis	0.0085	0.0085	CcSEcCtD
Metipranolol—Bradycardia—Prednisone—psoriatic arthritis	0.00837	0.00837	CcSEcCtD
Metipranolol—Discomfort—Prednisolone—psoriatic arthritis	0.00828	0.00828	CcSEcCtD
Metipranolol—Oedema—Prednisolone—psoriatic arthritis	0.00803	0.00803	CcSEcCtD
Metipranolol—Cough—Triamcinolone—psoriatic arthritis	0.0079	0.0079	CcSEcCtD
Metipranolol—Hypertension—Triamcinolone—psoriatic arthritis	0.00782	0.00782	CcSEcCtD
Metipranolol—Hypertension—Methylprednisolone—psoriatic arthritis	0.0078	0.0078	CcSEcCtD
Metipranolol—Myalgia—Triamcinolone—psoriatic arthritis	0.00771	0.00771	CcSEcCtD
Metipranolol—Myalgia—Methylprednisolone—psoriatic arthritis	0.00769	0.00769	CcSEcCtD
Metipranolol—Anxiety—Methylprednisolone—psoriatic arthritis	0.00766	0.00766	CcSEcCtD
Metipranolol—Discomfort—Triamcinolone—psoriatic arthritis	0.00761	0.00761	CcSEcCtD
Metipranolol—Discomfort—Methylprednisolone—psoriatic arthritis	0.0076	0.0076	CcSEcCtD
Metipranolol—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00744	0.00744	CcSEcCtD
Metipranolol—Oedema—Triamcinolone—psoriatic arthritis	0.00739	0.00739	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—psoriatic arthritis	0.00722	0.00722	CcSEcCtD
Metipranolol—Hypertension—Dexamethasone—psoriatic arthritis	0.00709	0.00709	CcSEcCtD
Metipranolol—Hypertension—Betamethasone—psoriatic arthritis	0.00709	0.00709	CcSEcCtD
Metipranolol—Myalgia—Betamethasone—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Metipranolol—Myalgia—Dexamethasone—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Metipranolol—Anxiety—Betamethasone—psoriatic arthritis	0.00697	0.00697	CcSEcCtD
Metipranolol—Anxiety—Dexamethasone—psoriatic arthritis	0.00697	0.00697	CcSEcCtD
Metipranolol—Discomfort—Betamethasone—psoriatic arthritis	0.00691	0.00691	CcSEcCtD
Metipranolol—Discomfort—Dexamethasone—psoriatic arthritis	0.00691	0.00691	CcSEcCtD
Metipranolol—Vision blurred—Prednisone—psoriatic arthritis	0.00674	0.00674	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00673	0.00673	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00672	0.00672	CcSEcCtD
Metipranolol—Oedema—Betamethasone—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Metipranolol—Oedema—Dexamethasone—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Metipranolol—Visual impairment—Methotrexate—psoriatic arthritis	0.00662	0.00662	CcSEcCtD
Metipranolol—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00659	0.00659	CcSEcCtD
Metipranolol—Hypertension—Prednisone—psoriatic arthritis	0.00618	0.00618	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00611	0.00611	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00611	0.00611	CcSEcCtD
Metipranolol—Myalgia—Prednisone—psoriatic arthritis	0.00609	0.00609	CcSEcCtD
Metipranolol—Anxiety—Prednisone—psoriatic arthritis	0.00607	0.00607	CcSEcCtD
Metipranolol—Discomfort—Prednisone—psoriatic arthritis	0.00602	0.00602	CcSEcCtD
Metipranolol—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00592	0.00592	CcSEcCtD
Metipranolol—Oedema—Prednisone—psoriatic arthritis	0.00584	0.00584	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—psoriatic arthritis	0.00563	0.00563	CcSEcCtD
Metipranolol—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00544	0.00544	CcSEcCtD
Metipranolol—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00543	0.00543	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00532	0.00532	CcSEcCtD
Metipranolol—Dizziness—Prednisolone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Metipranolol—Asthenia—Triamcinolone—psoriatic arthritis	0.0053	0.0053	CcSEcCtD
Metipranolol—Asthenia—Methylprednisolone—psoriatic arthritis	0.00529	0.00529	CcSEcCtD
Metipranolol—Cough—Methotrexate—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Metipranolol—Rash—Prednisolone—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Metipranolol—Dermatitis—Prednisolone—psoriatic arthritis	0.00506	0.00506	CcSEcCtD
Metipranolol—Headache—Prednisolone—psoriatic arthritis	0.00503	0.00503	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—psoriatic arthritis	0.00503	0.00503	CcSEcCtD
Metipranolol—Dizziness—Triamcinolone—psoriatic arthritis	0.00489	0.00489	CcSEcCtD
Metipranolol—Dizziness—Methylprednisolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Metipranolol—Asthenia—Betamethasone—psoriatic arthritis	0.00481	0.00481	CcSEcCtD
Metipranolol—Asthenia—Dexamethasone—psoriatic arthritis	0.00481	0.00481	CcSEcCtD
Metipranolol—Nausea—Prednisolone—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Metipranolol—Rash—Triamcinolone—psoriatic arthritis	0.00466	0.00466	CcSEcCtD
Metipranolol—Dermatitis—Triamcinolone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Metipranolol—Rash—Methylprednisolone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Metipranolol—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Metipranolol—Headache—Triamcinolone—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Metipranolol—Headache—Methylprednisolone—psoriatic arthritis	0.00462	0.00462	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Metipranolol—Dizziness—Dexamethasone—psoriatic arthritis	0.00443	0.00443	CcSEcCtD
Metipranolol—Dizziness—Betamethasone—psoriatic arthritis	0.00443	0.00443	CcSEcCtD
Metipranolol—Nausea—Triamcinolone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Metipranolol—Nausea—Methylprednisolone—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Metipranolol—Hypersensitivity—Prednisone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Metipranolol—Rash—Betamethasone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Metipranolol—Rash—Dexamethasone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Metipranolol—Dermatitis—Dexamethasone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Metipranolol—Dermatitis—Betamethasone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Metipranolol—Headache—Betamethasone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Metipranolol—Headache—Dexamethasone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Metipranolol—Asthenia—Prednisone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Metipranolol—Nausea—Betamethasone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Metipranolol—Nausea—Dexamethasone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Metipranolol—Dizziness—Prednisone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Metipranolol—Rash—Prednisone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Metipranolol—Dermatitis—Prednisone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Metipranolol—Headache—Prednisone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Metipranolol—Nausea—Prednisone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Metipranolol—Rash—Methotrexate—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Metipranolol—Headache—Methotrexate—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Metipranolol—Nausea—Methotrexate—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
